Treatment of ophthalmologic diseases

The current invention relates to the use of antibodies which bind to VEGF and ANG2 for the treatment of ophthalmologic diseases.

Saved in:
Bibliographic Details
Main Authors OSBORNE, AARON, WEIKERT, ROBERT JAMES, SAHNI, JAYASHREE
Format Patent
LanguageChinese
English
Published 11.02.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The current invention relates to the use of antibodies which bind to VEGF and ANG2 for the treatment of ophthalmologic diseases.
Bibliography:Application Number: TW20198104518